PeerVoice Heart & Lung Audio
By PeerVoice
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by PeerVoice
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 69
Description
PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Heart & Lung that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
| Episode | Date |
|---|---|
|
Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and Management
|
Jul 20, 2026 |
|
Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health
|
Jun 29, 2026 |
|
Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care Professional
|
May 18, 2026 |
|
Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa Inhibition
|
Apr 29, 2026 |
|
Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
|
Mar 06, 2026 |
|
Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
|
Feb 04, 2026 |
|
Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern Management
|
Jan 14, 2026 |
|
Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and Opportunities
|
Dec 31, 2025 |
|
John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes
|
Dec 23, 2025 |
|
Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?
|
Dec 16, 2025 |
|
Francesco Cappelli, MD, PhD - Meaningful Data From Madrid: Expanding Our Understanding of Phase 3s and OLEs in ATTR-CM
|
Nov 19, 2025 |
|
Emer Joyce, MB BCh BAO, PhD - Staying Ahead of the Curve in ATTR-CM: Adapting and Advancing Our Approach to Decision-Making as the Treatment Landscape Evolves
|
Nov 08, 2025 |
|
Alice M. Turner, MBChB, PhD - Cross-Talk Between Lung and Liver in Alpha-1 Antitrypsin Deficiency: A Call for Integrated Care
|
Oct 30, 2025 |
|
Solange Peters, MD, PhD - Pioneering Precision: A Real-World Roadmap to Optimal Outcomes in NTRK Fusion-Positive and HER2-Mutant Advanced NSCLC
|
Oct 03, 2025 |
|
Christie M. Ballantyne, MD - At the Forefront of the Latest Developments in FCS: Expert Perspectives on Emerging Evidence
|
Aug 27, 2025 |
|
Enriqueta Felip, MD, PhD - Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials?
|
Aug 19, 2025 |
|
Solange Peters, MD, PhD - Partnering With Patients: Shared Decision-Making in Locally Advanced, Unresectable EGFR-Mutated Non-Small Cell Lung Cancer
|
Jul 21, 2025 |
|
Marianna Fontana, MD, PhD / Julian Gillmore, MD, PhD, FRCP, FRCPath - Identifying Outcomes That Matter in ATTR-CM: Critical Considerations in the Interpretation of Contemporary Clinical Trials
|
Jun 30, 2025 |
|
Nicoletta Policek, PhD - When You Are Not an HIV Specialist But You Are Addressing Broader Healthcare Needs of Individuals With HIV: What Do You Need to Know?
|
May 30, 2025 |
|
Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care
|
Dec 27, 2024 |
|
Raffaele Califano, MD - At the Frontline in ALK+ NSCLC: Practical Approaches to TKI Therapy
|
Aug 02, 2024 |
|
Isabel Conceição, MD - Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making
|
Jul 22, 2024 |
|
Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia
|
Jul 03, 2024 |
|
Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy
|
Jul 03, 2024 |
|
Jonathan W. Riess, MD, MS - The Central Role of the Pathologist in Detecting MET Alterations: Enabling Multidisciplinary Teams to Do More With Less in NSCLC
|
Jun 03, 2024 |
|
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
|
Mar 26, 2024 |
|
Wisia Wedzicha, MD, FRCP - Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care
|
Mar 01, 2024 |
|
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
|
Feb 28, 2024 |
|
David M. G. Halpin, MB BS, DPhil, FERS - The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death
|
Jan 29, 2024 |
|
Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
|
Jan 03, 2024 |
|
Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations
|
Dec 28, 2023 |
|
Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD
|
Dec 27, 2023 |
|
Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations
|
Dec 21, 2023 |
|
Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers
|
Dec 01, 2023 |
|
Wong Seng Weng, MBBS, MRCP, FAMS - Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?
|
Sep 29, 2023 |
|
David Planchard, MD, PhD - Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
|
Sep 29, 2023 |
|
Sarah Jarvis, MBE, FRCGP - Achieving Shared Goals Across the Spectrum of CKD and HF
|
Aug 22, 2023 |
|
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?
|
Aug 22, 2023 |
|
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
|
Jul 26, 2023 |
|
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
|
Jul 24, 2023 |
|
Michael Thorpy, MD - Dual Duty: Protecting Cardiovascular Health in Patients With Narcolepsy
|
Jul 06, 2023 |
|
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
|
Jun 27, 2023 |
|
Sara A. Hurvitz, MD, FACP - Drug-Induced Interstitial Lung Disease and Breast Cancer: Knowing the Odds and Managing the Risk
|
Jun 19, 2023 |
|
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
|
Jun 19, 2023 |
|
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
|
May 05, 2023 |
|
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians
|
Apr 11, 2023 |
|
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies
|
Mar 30, 2023 |
|
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes
|
Mar 23, 2023 |
|
Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team
|
Feb 14, 2023 |
|
Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections
|
Jan 06, 2023 |
|
Perry Elliott, MD, FRCP, FESC - Thickening of the Heart, and HCM Is to Blame: A Call for Improved Recognition, Diagnosis, and Management of HCM
|
Dec 29, 2022 |
|
Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC
|
Dec 14, 2022 |
|
Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure
|
Dec 06, 2022 |
|
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
|
Dec 05, 2022 |
|
Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered
|
Nov 14, 2022 |
|
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
|
Oct 27, 2022 |
|
Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure
|
Oct 20, 2022 |
|
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice
|
Oct 03, 2022 |
|
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
|
Sep 29, 2022 |
|
Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC
|
Sep 20, 2022 |
|
New Biomarkers, New Targets in Advanced NSCLC
|
Aug 17, 2022 |
|
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
|
Jul 11, 2022 |
|
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
|
Jun 30, 2022 |
|
Evolving Clinical Management of the Hospitalised COVID-19 Patient
|
May 30, 2022 |
|
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
|
May 24, 2022 |
|
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID
|
May 18, 2022 |
|
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale is Compromised
|
May 18, 2022 |
|
Managing Complex Patients Hospitalized Due to COVID-19: Cases in Practice
|
May 16, 2022 |
|
Biologics in Asthma and Nasal Polyposis: Decision-Making in Practice
|
Mar 29, 2022 |